Phase I trial of the combination of bortezomib and clofarabine in adults with refractory tumors

Jibran Ahmed, Andre DeSouza, Shivaani Kummar, Lawrence Rubinstein, Geraldine O’Sullivan-Coyne, Jeevan Govindharajulu, William Herrick, Kate Ferry-Galow, Li Li, Deborah F. Wilsker, Murielle Hogu, Richard Piekarz, Robert Meehan, Mohamad Adham Salkeni, Sarah Shin, Brandon Miller, Jennifer Zlott, Lamin Juwara, Karen Gray, Laura Kuhlmann, Apurva Srivastava, Ralph E. Parchment, James H. Doroshow, Naoko Takebe, Alice P. Chen

Open source

DOI: 10.1007/s00280-026-04868-y
Published: 2026-03-14
Container: Cancer Chemotherapy and Pharmacology
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s00280-026-04868-y,
  title = {Phase I trial of the combination of bortezomib and clofarabine in adults with refractory tumors},
  author = {Jibran Ahmed and Andre DeSouza and Shivaani Kummar and Lawrence Rubinstein and Geraldine O’Sullivan-Coyne and Jeevan Govindharajulu and William Herrick and Kate Ferry-Galow and Li Li and Deborah F. Wilsker and Murielle Hogu and Richard Piekarz and Robert Meehan and Mohamad Adham Salkeni and Sarah Shin and Brandon Miller and Jennifer Zlott and Lamin Juwara and Karen Gray and Laura Kuhlmann and Apurva Srivastava and Ralph E. Parchment and James H. Doroshow and Naoko Takebe and Alice P. Chen},
  year = {2026},
  journal = {Cancer Chemotherapy and Pharmacology},
  doi = {10.1007/s00280-026-04868-y},
  url = {https://doi.org/10.1007/s00280-026-04868-y}
}

RIS

TY  - JOUR
TI  - Phase I trial of the combination of bortezomib and clofarabine in adults with refractory tumors
AU  - Jibran Ahmed
AU  - Andre DeSouza
AU  - Shivaani Kummar
AU  - Lawrence Rubinstein
AU  - Geraldine O’Sullivan-Coyne
AU  - Jeevan Govindharajulu
AU  - William Herrick
AU  - Kate Ferry-Galow
AU  - Li Li
AU  - Deborah F. Wilsker
AU  - Murielle Hogu
AU  - Richard Piekarz
AU  - Robert Meehan
AU  - Mohamad Adham Salkeni
AU  - Sarah Shin
AU  - Brandon Miller
AU  - Jennifer Zlott
AU  - Lamin Juwara
AU  - Karen Gray
AU  - Laura Kuhlmann
AU  - Apurva Srivastava
AU  - Ralph E. Parchment
AU  - James H. Doroshow
AU  - Naoko Takebe
AU  - Alice P. Chen
PY  - 2026
JO  - Cancer Chemotherapy and Pharmacology
DO  - 10.1007/s00280-026-04868-y
UR  - https://doi.org/10.1007/s00280-026-04868-y
ER  -

APA

Ahmed, J., DeSouza, A., Kummar, S., Rubinstein, L., O’Sullivan-Coyne, G., Govindharajulu, J., Herrick, W., Ferry-Galow, K., Li, L., Wilsker, D. F., Hogu, M., Piekarz, R., Meehan, R., Salkeni, M. A., Shin, S., Miller, B., Zlott, J., Juwara, L., Gray, K., Kuhlmann, L., Srivastava, A., Parchment, R. E., Doroshow, J. H., Takebe, N., & Chen, A. P. (2026). Phase I trial of the combination of bortezomib and clofarabine in adults with refractory tumors. Cancer Chemotherapy and Pharmacology. https://doi.org/10.1007/s00280-026-04868-y

Source records

crossref · retrieved 2026-09-25T19:35:59.337Z